
Similar Posts
Behavioral Economic Interventions – It’s Not a Choice Between Nudges and Shoves
The field of behavioral economics has brought attention to promising ways of motivating people to make better life choices. Many behavioral economic-inspired interventions are relatively hands off — they nudge people to make wiser decisions without in any way restricting their choices. The idea of nudges was made justifiably popular by Cass Sunstein and Dick Thaler…

Medicare Savings Might Be Costing Us: Here’s Why
Could ACOs be costing us money?

Medicare Pays More Money To Doctors Taking Care Of Rich Patients. Here’s Why.
It has always been financially rewarding for doctors to take care of rich patients. People with more money…well, they have more money to spend on healthcare. But shouldn’t this more money/higher payment relationship go away in Medicare? It doesn’t, and some recent payment reforms may be making matters worse. (To read the rest of the…

Drugs Are Outrageously Expensive—Canada Found A Way To Fight Back
Latuda is a drug to treat schizophrenia. It costs about $4,000 per month in the U.S. In Canada, the price is closer to $500.
Ibrance, a breast cancer drug, costs $10,000 more per month in the U.S. than in Canada.
Why these enormous price differences?

Science Isn’t Meant To Be Followed
Science cannot lead us out of this pandemic. Whatever paths we take to navigate COVID-19 need to be chosen through political processes. The true role of science is to illuminate these pathways, guiding our policy choices by showing us what’s at stake.

The Crushing Cost Of Tracking Healthcare Quality—One Hospital’s Story
A whole industry is devoted to measuring, tracking and even incentivizing the quality of American hospital care. Unfortunately, that industry is horribly inefficient, costing us billions of dollars.
Quality measurement is inefficient in large part because there is no single source that hospitals (and provider systems, more generally) can use to track the quality of their care.